Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-04 Disposition | 2024-10-11 6:13 pm | 2023-12-13 2025-06-13 | IN8BIO INC. | INAB | Kreis Leslie W. BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP Bios Equity Partners II LP BIOS Equity Partners III LP BP Directors LP Bios Equity Partners LP Cavu Management LP Cavu Advisors LLC 10% Owner | 574,241 | $0 | 11,862,579 (Indirect) | View |
2024-10-04 Option Award | 2024-10-11 6:13 pm | 2023-12-13 2025-10-04 | IN8BIO INC. | INAB | Kreis Leslie W. BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP Bios Equity Partners II LP BIOS Equity Partners III LP BP Directors LP Bios Equity Partners LP Cavu Management LP Cavu Advisors LLC 10% Owner | 574,241 | $0 | 11,862,579 (Indirect) | View |
2024-10-04 Disposition | 2024-10-11 6:12 pm | 2023-12-13 2025-06-13 | IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus Co-Invest I LP Bios Clinical Opportunity Fund LP Bios Equity COF LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 574,241 | $0 | 11,862,579 (Indirect) | View |
2024-10-04 Option Award | 2024-10-11 6:12 pm | 2023-12-13 2025-10-04 | IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus Co-Invest I LP Bios Clinical Opportunity Fund LP Bios Equity COF LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 574,241 | $0 | 11,862,579 (Indirect) | View |
2024-10-04 Disposition | 2024-10-08 4:15 pm | N/A 2025-06-13 | IN8BIO INC. | INAB | Rochlin Kate Chief Operating Officer | 12,295 | $0 | 80,485 (Direct) | View |
2024-10-04 Option Award | 2024-10-08 4:15 pm | N/A 2025-10-04 | IN8BIO INC. | INAB | Rochlin Kate Chief Operating Officer | 37,611 | $0 | 80,485 (Direct) | View |
2024-10-04 Disposition | 2024-10-08 4:15 pm | N/A 2025-06-13 | IN8BIO INC. | INAB | McCall Patrick CHIEF FINANCIAL OFFICER | 20,492 | $0 | 97,879 (Direct) | View |
2024-10-04 Option Award | 2024-10-08 4:15 pm | N/A 2025-10-04 | IN8BIO INC. | INAB | McCall Patrick CHIEF FINANCIAL OFFICER | 45,808 | $0 | 97,879 (Direct) | View |
2024-10-04 Disposition | 2024-10-08 4:15 pm | N/A 2025-06-13 | IN8BIO INC. | INAB | Roemer Alan S. Director | 102,459 | $0 | 514,071 (Direct) | View |
2024-10-04 Option Award | 2024-10-08 4:15 pm | N/A 2025-10-04 | IN8BIO INC. | INAB | Roemer Alan S. Director | 229,041 | $0 | 514,071 (Direct) | View |
2024-10-04 Disposition | 2024-10-08 4:15 pm | N/A 2025-06-13 | IN8BIO INC. | INAB | Brandt Peter C. Director | 81,967 | $0 | 958,025 (Direct) | View |
2024-10-04 Option Award | 2024-10-08 4:15 pm | N/A 2025-10-04 | IN8BIO INC. | INAB | Brandt Peter C. Director | 335,131 | $0 | 958,025 (Direct) | View |
2024-10-04 Disposition | 2024-10-08 4:15 pm | N/A 2025-06-13 | IN8BIO INC. | INAB | Ho William Tai-Wei PRESIDENT AND CEO 10% Owner | 81,967 | $0 | 3,012,142 (Direct) | View |
2024-10-04 Option Award | 2024-10-08 4:15 pm | N/A 2025-10-04 | IN8BIO INC. | INAB | Ho William Tai-Wei PRESIDENT AND CEO 10% Owner | 208,549 | $0 | 3,012,142 (Direct) | View |
2024-09-04 Option Award | 2024-09-05 4:35 pm | N/A 2034-09-04 | IN8BIO INC. | INAB | Rochlin Kate Chief Operating Officer | 250,000 | $0 | 250,000 (Direct) | View |
2024-09-04 Option Award | 2024-09-05 4:35 pm | N/A 2034-09-04 | IN8BIO INC. | INAB | McCall Patrick CHIEF FINANCIAL OFFICER | 250,000 | $0 | 250,000 (Direct) | View |
2024-09-04 Option Award | 2024-09-05 4:35 pm | N/A 2034-09-04 | IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO | 250,000 | $0 | 250,000 (Direct) | View |
2024-09-04 Option Award | 2024-09-05 4:35 pm | N/A 2034-09-04 | IN8BIO INC. | INAB | Ho William Tai-Wei PRESIDENT AND CEO 10% Owner | 500,000 | $0 | 500,000 (Direct) | View |
2024-09-04 Option Award | 2024-09-05 4:35 pm | N/A 2034-09-04 | IN8BIO INC. | INAB | Goswami Trishna Chief Medical Officer | 250,000 | $0 | 250,000 (Direct) | View |
2024-06-12 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-12 | IN8BIO INC. | INAB | Whitfill Travis Director | 33,650 | $0 | 33,650 (Direct) | View |
2024-06-12 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-12 | IN8BIO INC. | INAB | Greenwood Luba Director | 33,650 | $0 | 33,650 (Direct) | View |
2024-06-12 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-12 | IN8BIO INC. | INAB | Graff Jeremy R. Director | 33,650 | $0 | 33,650 (Direct) | View |
2024-06-12 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-12 | IN8BIO INC. | INAB | FAIRBAIRN EMILY Director | 33,650 | $0 | 33,650 (Direct) | View |
2024-06-12 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-12 | IN8BIO INC. | INAB | Epperly Corinne Director | 33,650 | $0 | 33,650 (Direct) | View |
2024-06-12 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-12 | IN8BIO INC. | INAB | Brandt Peter C. Director | 33,650 | $0 | 33,650 (Direct) | View |
2024-06-12 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-12 | IN8BIO INC. | INAB | Roemer Alan S. Director | 33,650 | $0 | 33,650 (Direct) | View |
2024-02-07 Option Award | 2024-02-08 4:54 pm | N/A 2034-02-07 | IN8BIO INC. | INAB | Epperly Corinne Director | 12,500 | $0 | 12,500 (Direct) | View |
2024-02-07 Option Award | 2024-02-08 4:52 pm | N/A 2034-02-07 | IN8BIO INC. | INAB | Ho William Tai-Wei PRESIDENT AND CEO 10% Owner | 502,000 | $0 | 502,000 (Direct) | View |
2024-02-07 Option Award | 2024-02-08 4:50 pm | N/A 2034-02-07 | IN8BIO INC. | INAB | Goswami Trishna CHIEF MEDICAL OFFICER | 176,000 | $0 | 176,000 (Direct) | View |
2024-02-07 Option Award | 2024-02-08 4:49 pm | N/A 2034-02-07 | IN8BIO INC. | INAB | Rochlin Kate CHIEF OPERATING OFFICER | 186,000 | $0 | 186,000 (Direct) | View |
2024-02-07 Option Award | 2024-02-08 4:47 pm | N/A 2034-02-07 | IN8BIO INC. | INAB | Lamb Lawrence EVP AND CSO | 169,000 | $0 | 169,000 (Direct) | View |
2024-02-07 Option Award | 2024-02-08 4:46 pm | N/A 2034-02-07 | IN8BIO INC. | INAB | McCall Patrick CHIEF FINANCIAL OFFICER | 189,000 | $0 | 189,000 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 08:27 am | N/A 2025-06-13 | IN8BIO INC. | INAB | Graff Jeremy R. Director | 4,098 | $0 | 8,647 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 08:26 am | N/A 2025-06-13 | IN8BIO INC. | INAB | Epperly Corinne Director | 163,934 | $0 | 245,901 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 08:25 am | N/A 2025-06-13 | IN8BIO INC. | INAB | Roemer Alan S. Director | 204,918 | $0 | 363,366 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 08:24 am | N/A 2025-06-13 | IN8BIO INC. | INAB | Ho William Tai-Wei President and CEO 10% Owner | 163,934 | $0 | 2,840,945 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 08:23 am | N/A 2025-06-13 | IN8BIO INC. | INAB | McCall Patrick Chief Financial Officer | 40,984 | $0 | 67,739 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 08:22 am | N/A 2025-06-13 | IN8BIO INC. | INAB | Rochlin Kate Chief Operating Officer | 24,590 | $0 | 42,148 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 08:20 am | N/A 2025-06-13 | IN8BIO INC. | INAB | Goswami Trishna Chief Medical Officer | 8,196 | $0 | 14,925 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 08:19 am | N/A 2025-06-13 | IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO | 3,278 | $0 | 104,647 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 08:18 am | N/A 2025-06-13 | IN8BIO INC. | INAB | Brandt Peter C. Director | 163,934 | $0 | 533,664 (Direct) | View |
Ownership | 2023-12-15 06:02 am | 2023-12-13 N/A | IN8BIO INC. | INAB | Bios Clinical Opportunity Fund LP Bios Equity COF LP 10% Owner | 0 | $0 | 1,722,723 (Direct) | View |
2023-12-06 Option Award | 2023-12-08 4:26 pm | N/A 2033-12-06 | IN8BIO INC. | INAB | Epperly Corinne Director | 54,800 | $0 | 54,800 (Direct) | View |